Re: Platelet associated immunoglobulins

From: Bruce Davis (DAVISB@mmc.org)
Date: Fri Jun 01 2001 - 15:28:29 EST


The method that I have found useful is to incubate normal platelets with serum/plasma
from a patient with anti-platelet antibodies (or commercial serum with anti-platelet
reactivity).  It is as follows:

 POSITIVE CONTROLS

	1.	Collect six EDTA tubes from a known normal individual. Try to always
	use the same individual in order to minimize the variation in the mean channel
	results of the quality control files.
	2.	 Isolate platelets as described for patients following steps 1 - 4 only.
	3.	To the platelet pellet add 500 ul of saturating anti-PLA serum. This
	is the "Positive" control.
	4.	Following a 30' incubation on ice, wash the sensitized control x 2
	with 10 ml of BSA/Tyrode's.
	5.	Resuspend the final pellet in 1.8 ml of BSA/Tyrode's and 600 mL of 4%
	formaldehyde and place the tube in the refrigerator for one hour.
	6.	 Following a 60' incubation in the refrigerator wash the positive
	control x 2 with 10 ml of     BSA/Tyrode's. Resuspend the final pellet in 5 ml of
	BSA/Tyrode's and measure the platelet count.  Adjust the volume so that the final
	platelet count is 1x108/ml. Store in the refrigerator until the time of assay.
	7.		Assay the new positive control in parallel with the current
	positive control.  If the new positive control does not fall within the
	previously established ranges of the quality control files, consult the
	supervisor for direction.

	Note: If the same individual's platelets with the same PLA1+ serum are used
	every time the mean channel of fluorescence should fall within the previously
	established ranges of  the quality control files.

	8.		When a 50% loss of fluorescence intensity of the positive
	control is noted, make a new positive control.

NEGATIVE CONTROLS:

	1.	Negative controls are obtained by using the platelet preparations from
	previously tested negative patient specimens.

NORMAL CONTROLS:

	1.		A normal control is obtained by isolating the platelets from
	a hematologically normal   individual. It should not be prepared more than
	two days prior to the staining procedure.


Regards,



Bruce H. Davis, M.D.
Maine Medical Center Research Institute
81 Research Drive
Scarborough, Maine  04074
USA

PHONE: 207-885-8113
FAX: 207-885-8110
Email:	davisb@mmc.org

>>> "Dr. Michael Brown" <mbrown@ypii.com> 05/31/01 04:55PM >>>

We are currently working on bringing a platelet-associated Ig assay by flow
on line and are looking for good positive control material.  It is unlikely
that our initial volume for this test will be sufficient to allow use of
previous patient positives from day to day.  We are aware of a couple of
ELISA kits, but they are quite expensive.  Does the group have any
suggestions for positive controls for this assay?  Thank you in advance.

Michael


Michael Brown, MD
Yellowstone Pathology Institute
Billings, MT
406-238-6360



This archive was generated by hypermail 2b29 : Sun Jan 05 2003 - 19:01:21 EST